Email this article Bronchiectasis
- Authors: Chuchalin AG1
-
Affiliations:
- Научно-исследовательский институт пульмонологии ФМБА России
- Issue: Vol 89, No 3 (2017)
- Pages: 4-17
- Section: Editorial
- URL: https://journals.rcsi.science/0040-3660/article/view/32146
- DOI: https://doi.org/10.17116/terarkh20178934-17
- ID: 32146
Cite item
Full Text
Abstract
The paper presents information on possible approaches to the classification, pathogenesis, and determination of the etiological causes of bronchiectasis. It discusses a group of bronchiectasis-associated diseases. It gives a detailed diagnostic algorithm aimed to establish the etiology of bronchiectasis and the markers of the efficiency of different treatment options. Much attention is paid to genetically predetermined bronchiectasis. Universal approaches to treating patients with bronchiectasis as a whole, as well as treatments for certain entities of bronchiectasis are discussed.
Full Text
##article.viewOnOriginalSite##About the authors
A G Chuchalin
Научно-исследовательский институт пульмонологии ФМБА РоссииМосква, Россия
References
- Улумбеков Э.Г. Большой энциклопедический словарь медицинских терминов. Геотар-Медиа. M.: 2012.
- Цигельник А.Я.Бронхоэктатическая болезнь. Государственное издательство медицинской литературы. 1948 г.
- Weycker D, Edelsberg J, Oster G, Tino G. Prevalence and Economic Burden of Bronchiectasis. Clinical Pulmonary Medicine. 2005;12(4):205-209. doi: 10.1097/01.cpm.0000171422.98696.ed
- Nadel J, Murray J, Masson R, Ernst J. Textbook of respiratory medicine. sixth edition. Philadelphia: Elsevier Saunders; 2014:853-877.
- Costerton J. The Etiology and Persistence of Cryptic Bacterial Infections: A Hypothesis. Clinical Infectious Diseases. 1984; 6(Suppl.3): S608-S616. doi: 10.1093/clinids/6.supplement_3.s608
- Mason A, Gasnier C, Kichler A et al. Enhanced Membrane Disruption and Antibiotic Action against Pathogenic Bacteria by Designed Histidine-Rich Peptides at Acidic pH. Antimicrobial Agents and Chemotherapy. 2006;50(10):3305-3311. doi: 10.1128/aac.00490-06
- Муковисцидоз: монография. Под ред. Капранова Н.И., Каширской Н.Ю.: Медпрактика; 2014:глава 10.
- Freeman A, Holland S. The Hyper-IgE Syndromes. Immunology and Allergy Clinics of North America. 2008;28(2):277-291. doi: 10.1016/j.iac.2008.01.005
- Parr D, Guest P, Reynolds J, Dowson L, Stockley R. Prevalence and Impact of Bronchiectasis in α1-Antitrypsin Deficiency. American Journal of Respiratory and Critical Care Medicine. 2007;176(12):1215-1221. doi: 10.1164/rccm.200703-489oc
- de Serres F. Worldwide Racial and Ethnic Distribution of α1-Antitrypsin Deficiency. Chest. 2002;122(5):1818-1829. doi: 10.1378/chest.122.5.1818
- Lieberman J. Augmentation Therapy Reduces Frequency of Lung Infections in Antitrypsin Deficiency. Chest. 2000;118(5):1480-1485. doi: 10.1378/chest.118.5.1480
- SHAPIRO L. Alpha-1-antitrypsin inhibits human immunodeficiency virus type 1. The FASEB Journal. 2001;15(1):115-122. doi: 10.1096/fj.00-0311com
- Chan E, Kaminska A, Gill W et al. Alpha-1-antitrypsin (AAT) anomalies are associated with lung disease due to rapidly growing mycobacteria and AAT inhibits Mycobacterium abscessus infection of macrophages. Scandinavian Journal of Infectious Diseases. 2007;39(8):690-696. doi: 10.1080/00365540701225744
- Поливанов Г.Э.Структурно-денситометрический анализ ткани легких у больных ХОБЛ: Автореф. дисс. ... канд. мед. наук. Москва; 2008. Ссылка активна на 11.11.2016. Доступно по: www.pulmonology.ru/publications/files/dissertations/POLIVANOv.doc
- Martínez-García M, de la Rosa Carrillo D, Soler-Cataluña J et al. Prognostic Value of Bronchiectasis in Patients with Moderate-to-Severe Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 2013;187(8):823-831. doi: 10.1164/rccm.201208-1518oc
- Noone P, Leigh M, Sannuti A et al. Primary Ciliary Dyskinesia. American Journal of Respiratory and Critical Care Medicine. 2004;169(4):459-467. doi: 10.1164/rccm.200303-365oc
- Марченков Я.В. Дивертикулы трахеи. Тер. архив. 2013;85 (10):119-121.
- Kartalija M, Ovrutsky A, Bryan C et al. Patients with Nontuberculous Mycobacterial Lung Disease Exhibit Unique Body and Immune Phenotypes. American Journal of Respiratory and Critical Care Medicine. 2013;187(2):197-205. doi: 10.1164/rccm.201206-1035oc
- Judge Dietz H. Marfan’s syndrome. The Lancet. 2005;366 (9501):1965-1976. doi: 10.1016/s0140-6736(05)67789-6
- Reich Johnson R. Mycobacterium avium Complex Pulmonary Disease Presenting as an Isolated Lingular or Middle Lobe Pattern. Chest. 1992;101(6):1605-1609. doi: 10.1378/chest.101.6.1605
- Perez T, Remy-Jardin M, Cortet B. Airways Involvement in Rheumatoid Arthritis. American Journal of Respiratory and Critical Care Medicine. 1998;157(5):1658-1665. doi: 10.1164/ajrccm.157.5.9710018
- Swinson D, Symmons D, Suresh U, Jones M, Booth J. Decreased survival in patients with co-existent rheumatoid arthritis and bronchiectasis. Rheumatology. 1997;36(6):689-691. doi: 10.1093/rheumatology/36.6.689
- Boyton R, Smith J, Jones M et al. Human leucocyte antigen class II association in idiopathic bronchiectasis, a disease of chronic lung infection, implicates a role for adaptive immunity. Clinical & Experimental Immunology. 2008;152(1):95-101. doi: 10.1111/j.1365-2249.2008.03596.x
- Murray M, Govan J, Doherty C et al. A Randomized Controlled Trial of Nebulized Gentamicin in Non—Cystic Fibrosis Bronchiectasis. American Journal of Respiratory and Critical Care Medicine. 2011;183(4):491-499. doi: 10.1164/rccm.201005-0756oc
- Lands LC, Stanojevic S. Oral non-steroidal anti-inflammatory drug therapy for cystic fibrosis. Cochrane Database Syst Rev. 2007;(4):CD001505. doi: 10.1002/14651858.CD001505.pub2
- Serisier D, Martin M, McGuckin M et al. Effect of Long-term, Low-Dose Erythromycin on Pulmonary Exacerbations Among Patients With Non—Cystic Fibrosis Bronchiectasis. JAMA. 2013;309(12):1260. doi: 10.1001/jama.2013.2290
- Chalmers J, McHugh B, Docherty C, Govan J, Hill A. Vitamin-D deficiency is associated with chronic bacterial colonisation and disease severity in bronchiectasis. Thorax. 2012;68(1):39-47. doi: 10.1136/thoraxjnl-2012-202125
